Cargando…
The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
BACKGROUND: Vancomycin (VCM) treatment outcomes depend on the characteristics of the patient, and it is well known that hypoalbuminemia is a risk factor for poor treatment outcomes, as reported in a previous study. However, the reason that severe hypoalbuminemia has an influence on the treatment out...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793010/ https://www.ncbi.nlm.nih.gov/pubmed/24109180 http://dx.doi.org/10.2147/CIA.S52259 |
_version_ | 1782286920720580608 |
---|---|
author | Mizuno, Tomohiro Mizokami, Fumihiro Fukami, Kazuhiro Ito, Kazuhiro Shibasaki, Masataka Nagamatsu, Tadashi Furuta, Katsunori |
author_facet | Mizuno, Tomohiro Mizokami, Fumihiro Fukami, Kazuhiro Ito, Kazuhiro Shibasaki, Masataka Nagamatsu, Tadashi Furuta, Katsunori |
author_sort | Mizuno, Tomohiro |
collection | PubMed |
description | BACKGROUND: Vancomycin (VCM) treatment outcomes depend on the characteristics of the patient, and it is well known that hypoalbuminemia is a risk factor for poor treatment outcomes, as reported in a previous study. However, the reason that severe hypoalbuminemia has an influence on the treatment outcome of VCM remains unknown. OBJECTIVE: To elucidate the association between severe hypoalbuminemia and VCM treatment outcomes, we examined pharmacokinetic/pharmacodynamic (PK/PD) parameters in elderly patients with severe hypoalbuminemia. METHODS: We conducted a retrospective observational study of 94 patients with methicillin-resistant Staphylococcus aureus (MRSA) hospital-acquired pneumonia who had been treated with VCM between January 2006 and December 2012. The 94 patients were divided into severe hypoalbuminemia and non-severe hypoalbuminemia groups. The PK/PD parameters and treatment outcomes of VCM were compared between the two groups. RESULTS: The half-life of VCM in the severe hypoalbuminemia group was significantly longer than in the non-severe hypoalbuminemia group (33.2 + 5.4 vs 24.9 + 1.6; P = 0.049). Area under the concentration curve (AUC)/minimum inhibitory concentration (MIC) values of 250–450 and >450 μg × h/mL were significantly associated with 28-day mortality in the severe hypoalbuminemia group (P < 0.001), whereas AUC/MIC values of <250 μg × h/mL were not associated. We also detected a significant difference in the increased percentage of nephrotoxicity in the severe hypoalbuminemia group (6 of 23 patients [26%]) compared with the non-severe hypoalbuminemia group (6 of 71 patients [8%]; P < 0.001). CONCLUSION: These findings indicate that severe hypoalbuminemia influences the half-life of VCM and treatment outcomes in elderly patients (≥75 years of age). To establish a more effective and safer treatment protocol, the issue of malnutrition in elderly patients needs to be addressed and improved. |
format | Online Article Text |
id | pubmed-3793010 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-37930102013-10-09 The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia Mizuno, Tomohiro Mizokami, Fumihiro Fukami, Kazuhiro Ito, Kazuhiro Shibasaki, Masataka Nagamatsu, Tadashi Furuta, Katsunori Clin Interv Aging Original Research BACKGROUND: Vancomycin (VCM) treatment outcomes depend on the characteristics of the patient, and it is well known that hypoalbuminemia is a risk factor for poor treatment outcomes, as reported in a previous study. However, the reason that severe hypoalbuminemia has an influence on the treatment outcome of VCM remains unknown. OBJECTIVE: To elucidate the association between severe hypoalbuminemia and VCM treatment outcomes, we examined pharmacokinetic/pharmacodynamic (PK/PD) parameters in elderly patients with severe hypoalbuminemia. METHODS: We conducted a retrospective observational study of 94 patients with methicillin-resistant Staphylococcus aureus (MRSA) hospital-acquired pneumonia who had been treated with VCM between January 2006 and December 2012. The 94 patients were divided into severe hypoalbuminemia and non-severe hypoalbuminemia groups. The PK/PD parameters and treatment outcomes of VCM were compared between the two groups. RESULTS: The half-life of VCM in the severe hypoalbuminemia group was significantly longer than in the non-severe hypoalbuminemia group (33.2 + 5.4 vs 24.9 + 1.6; P = 0.049). Area under the concentration curve (AUC)/minimum inhibitory concentration (MIC) values of 250–450 and >450 μg × h/mL were significantly associated with 28-day mortality in the severe hypoalbuminemia group (P < 0.001), whereas AUC/MIC values of <250 μg × h/mL were not associated. We also detected a significant difference in the increased percentage of nephrotoxicity in the severe hypoalbuminemia group (6 of 23 patients [26%]) compared with the non-severe hypoalbuminemia group (6 of 71 patients [8%]; P < 0.001). CONCLUSION: These findings indicate that severe hypoalbuminemia influences the half-life of VCM and treatment outcomes in elderly patients (≥75 years of age). To establish a more effective and safer treatment protocol, the issue of malnutrition in elderly patients needs to be addressed and improved. Dove Medical Press 2013 2013-09-30 /pmc/articles/PMC3793010/ /pubmed/24109180 http://dx.doi.org/10.2147/CIA.S52259 Text en © 2013 Mizuno et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Mizuno, Tomohiro Mizokami, Fumihiro Fukami, Kazuhiro Ito, Kazuhiro Shibasaki, Masataka Nagamatsu, Tadashi Furuta, Katsunori The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia |
title | The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia |
title_full | The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia |
title_fullStr | The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia |
title_full_unstemmed | The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia |
title_short | The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia |
title_sort | influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant staphylococcus aureus hospital-acquired pneumonia |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793010/ https://www.ncbi.nlm.nih.gov/pubmed/24109180 http://dx.doi.org/10.2147/CIA.S52259 |
work_keys_str_mv | AT mizunotomohiro theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia AT mizokamifumihiro theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia AT fukamikazuhiro theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia AT itokazuhiro theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia AT shibasakimasataka theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia AT nagamatsutadashi theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia AT furutakatsunori theinfluenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia AT mizunotomohiro influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia AT mizokamifumihiro influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia AT fukamikazuhiro influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia AT itokazuhiro influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia AT shibasakimasataka influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia AT nagamatsutadashi influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia AT furutakatsunori influenceofseverehypoalbuminemiaonthehalflifeofvancomycininelderlypatientswithmethicillinresistantstaphylococcusaureushospitalacquiredpneumonia |